共 170 条
- [41] Raffone A(2018)Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow-up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma Mod Pathol 38 S40-1149
- [42] Travaglino A(2018)Does a p53 “wild-type” immunophenotype exclude a diagnosis of endometrial serous carcinoma? Adv Anat Pathol 38 S93-undefined
- [43] Mascolo M(2016)Molecular pathology: predictive, prognostic, and diagnostic markers in uterine tumors Surg Pathol Clin 96 e6976-undefined
- [44] Insabato L(2017)A selected immunohistochemical panel aids in differential diagnosis and prognostic stratification of subtypes of high-grade endometrial carcinoma: a clinicopathologic and immunohistochemical study at a single institution Appl Immunohistochem Mol Morphol 44 1140-undefined
- [45] Zullo F(2015)SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma Pathology undefined undefined-undefined
- [46] Travaglino A(2016)Molecular genetic heterogeneity in undifferentiated endometrial carcinomas Mod Pathol undefined undefined-undefined
- [47] Raffone A(2017)Undifferentiated and dedifferentiated endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis Am J Surg Pathol undefined undefined-undefined
- [48] Saccone G(2018)Undifferentiated endometrial carcinomas show frequent loss of core switch/sucrose nonfermentable complex proteins Am J Surg Pathol undefined undefined-undefined
- [49] Travaglino A(2018)Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: evaluation of the pilot phase of the PORTEC-4a trial Gynecol Oncol undefined undefined-undefined
- [50] Raffone A(2018)Clinical utility of prospective molecular characterization in advanced endometrial cancer Clin Cancer Res undefined undefined-undefined